HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figures and Tables All Versions of this Article: 296/5/H1660    most recent 00028.2009v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Cassis, L. A. Articles by Daugherty, A. Search for Related Content PubMed PubMed Citation Articles by Cassis, L. A. Articles by Daugherty, A.

ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice

¹Graduate Center for Nutritional Sciences, ²Graduate Center for Toxiology, ³Department of Statistics and ⁴Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky

Submitted 12 January 2009 ; accepted in final form 24 February 2009

Infusion of ANG II in hyperlipidemic mice augments atherosclerosis and causes formation of abdominal aortic aneurysms (AAAs). The purpose of this study was to define the contribution of ANG II-induced hypertension to these vascular pathologies. Male apolipoprotein E (apoE)- and LDL receptor (LDLr)-deficient mice were infused with ANG II (1,000 ng·kg^–1·min^–1) or norepinephrine (NE; 5.6 mg·kg^–1·day^–1) for 28 days. Infusion of ANG II or NE increased mean arterial pressure (MAP; ANG II, 133 ± 2.8; NE, 129 ± 13 mmHg) to a similar extent compared with baseline blood pressures (MAP, 107 ± 2 mmHg). Abdominal aortic width increased in both apoE-deficient (apoE^–/–) or LDLr-deficient (LDLr^–/–) mice infused with ANG II (apoE^–/–: 1.4 ± 0.1; LDLr^–/–: 1.6 ± 0.2 mm). In contrast, NE did not change diameters of abdominal aortas (apoE^–/–: 0.91 ± 0.03; LDLr^–/–: 0.87 ± 0.02 mm). Similarly, atherosclerotic lesions in aortic arches were much greater in mice infused with ANG II compared with NE. At a subpressor infusion rate of ANG II (500 ng·kg^–1·min^–1), AAAs developed in 50% of apoE^–/– mice. Alternatively, administration of hydralazine (250 mg/l) to ANG II-infused apoE^–/– mice (1,000 ng·kg^–1·min^–1) lowered systolic blood pressure (day 28: ANG II, 157 ± 6; ANG II/hydralazine, 135 ± 6 mmHg) but did not prevent AAA formation or atherosclerosis. These results demonstrate that infusion of ANG II to hyperlipidemic mice induces AAAs and augments atherosclerosis independent of increased blood pressure.

aneurysms; hypertension; vascular lesions

This article has been cited by other articles:

				A. Jones, R. Deb, E. Torsney, F. Howe, M. Dunkley, Y. Gnaneswaran, D. Gaze, H. Nasr, I. M. Loftus, M. M. Thompson, et al. Rosiglitazone Reduces the Development and Rupture of Experimental Aortic Aneurysms Circulation, June 23, 2009; 119(24): 3125 - 3132. [Abstract] [Full Text] [PDF]